New Karolinska Solna (NKS) is the project name for the state-of-the-art hospital currently under construction next to Karolinska University Hospital in Solna. The assignment for the new university hospital, which will open its doors to the first patients at the end of 2016, is to provide highly specialized healthcare to the 2.5 million population in the region and to conduct basic research, patient-focused clinical research as well as education. Greater collaboration between healthcare and research will contribute to new research findings being turned into new treatment methods and medicines faster.

Go to Nya Karolinska Solna

Located in central Stockholm, the city’s largest ever development project, Hagastaden, is well underway. The area is devoted to life science and encompasses all the elements required to become a true international hub. Karolinska Institutet, KTH Royal Institute of Technology, Stockholm University, SciLifeLab, Stockholm School of Economics and the existing and new Karolinska University Hospital are all within walking distance. This means that within a radius of two kilometres, there are four major universities, some of the world’s best clinical research facilities, leading healthcare providers, and one of Europe’s highest concentrations of life science companies, organisations and institutes.

Major investments in clusters, life science and healthcare facilities are also under way in other cities in Sweden. Examples include:

• The Skandion Clinic in Uppsala, the first clinic for proton therapy in Scandinavia. The first patient was treated in 2015.
• Re-building and expansion of Uppsala University Hospital, planned to be ready by 2022. A major investment of approximately 600 million Euros.
• A new Centre for Imaging and Intervention at Sahlgrenska University Hospital in Gothenburg, a 200 million Euro investment, due for completion in 2016.
• A new hub for biomedical translational research (Sahlgrenska Life) at Northern Europe´s largest hospital, in central Gothenburg. At an early stage of development, the core concept is to create an environment for seamless collaboration between industry, healthcare, research and education.
• In Lund, the Max IV and ESS investments in physical research infrastructure for use in several scientific branches exceed 2 billion Euros.
• A new Medical Biology Centre (MBC) at Umeå University enabling the Faculty of Medicine to co-locate its activities and gather its medical cutting edge research under one roof. An investment of almost 30 million Euros.